Similar articles

• Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients.

  Purtilo DT, Tatsumi E, Manolov G, Manolova Y, Harada S, Lipscomb H, Krueger G. Purtilo DT, et al. Int Rev Exp Pathol. 1985;27:113-83. Int Rev Exp Pathol. 1985. PMID: 3017882 Review. No abstract available.
• Opportunistic non-Hodgkin's lymphoma in X-linked recessive immunodeficiency and lymphoproliferative syndromes.

  Purtilo DT. Purtilo DT. Semin Oncol. 1977 Sep;4(3):335-43. Semin Oncol. 1977. PMID: 21454 No abstract available.
• Lymphoma, immunodeficiency and the Epstein-Barr virus.

  Rosen FS. Rosen FS. N Engl J Med. 1977 Nov 17;297(20):1120-1. doi: 10.1056/NEJM197711172972010. N Engl J Med. 1977. PMID: 198662 No abstract available.
• Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model.

  Purtilo DT. Purtilo DT. Adv Cancer Res. 1981;34:279-312. doi: 10.1016/s0065-230x(08)60244-4. Adv Cancer Res. 1981. PMID: 6269372 Review. No abstract available.
• Epstein-Barr virus and human disease: immune responses determine the clinical and pathologic expression.

  Purtilo DT, Sakamoto K. Purtilo DT, et al. Hum Pathol. 1981 Aug;12(8):677-9. doi: 10.1016/s0046-8177(81)80162-1. Hum Pathol. 1981. PMID: 6269987 Review. No abstract available.